Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu(Inserm), Velimir A. Luketic(University of Padua), Juan F. Gallegos‐Orozco(Radboud University Nijmegen), Dean W. Hum(Genfit (France)), Tarik Asselah(Inserm), U. Spengler(Virginia Commonwealth University), Manal F. Abdelmalek(Mayo Clinic), George Abouda, S. Megnien(Genfit (France)), Ulrich Beuers(Amsterdam University Medical Centers), Marc Bourlière(Universität Hamburg), Jérôme Gournay(Radboud University Nijmegen), David Cassiman, Javier Crespo(Universidad de Cantabria), Liliana Preoțescu(Virginia Commonwealth University), Dominique Larrey, Raúl J. Andrade(Hospital Clínico Universitario Virgen de la Victoria), Aftab Ala(Al-Ahliyya Amman University), Steve Caldwell(University of Virginia), Manuel Romero‐Gómez(Instituto de Biomedicina de Sevilla), Pierre Bédossa(Régie Autonome des Transports Parisiens (France)), Elisabetta Bugianesi(University of Turin), Victor de Lédinghen(Hôpital Cardiologique du Haut-Lévêque), A. Roudot(Genfit (France)), Lawrence Serfaty(Inserm), Quentin M. Anstee(Newcastle upon Tyne Hospital), M. Angélico, Juan Caballería(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Albert Tran, M. Maynard-Muet(Genfit (France)), Jérôme Boursier(Michael E. DeBakey VA Medical Center), Peter R. Galle(Johannes Gutenberg University Mainz), Arun J. Sanyal(Virginia Commonwealth University), Christophe Moreno(Genfit (France)), Sven Francque(Inova Health System), Éric Nguyen-Khac(Université de Lille), Joost P.H. Drenth(Amsterdam Neuroscience), Liliana Gheorghe(Virginia Commonwealth University), J.L. Callera, Frederik Nevens(KU Leuven), Silvia Fargion(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Guruprasad P. Aithal(NIHR Nottingham Digestive Diseases Biomedical Research Unit), Rémy Hanf(Genfit (France)), Stephen A. Harrison(Pinnacle Clinical Research), Antonio Craxı̀(University of Palermo), Philippe Mathurin(Centre Hospitalier Universitaire de Lille), M Voiculescu(Genfit (France)), Bart Staels(Inserm), Jean Henrion(Hôpital de Jolimont), Anja Geerts, Philippe Lehert(The University of Melbourne)
Cited by 1,013
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k